Organized by Bilkent University UNAM (National Nanotechnology Research Center), the Advanced Cancer Biotherapeutics Symposium (ACTS ’24) is scheduled to take place on October 4-5. This symposium will bring together clinicians, academics, graduate students and industry partners to explore cutting-edge technologies and therapies in cancer treatment.
ACTS ‘24 marks the beginning of an annual platform for sharing knowledge and fostering collaborations in the field of cancer biotherapeutics. This inaugural event brings together leading experts to discuss the latest advancements in cancer treatment and to set the stage for future gatherings dedicated to this vital area of research.
The two-day program is packed with keynote lectures, invited talks, lightning presentations and networking opportunities.
